In recent years, the cannabinoid industry has experienced significant growth and evolution, driven by changing laws and attitudes towards cannabis and its derivatives. To understand the landscape of this rapidly expanding sector, it is crucial to delve into the latest statistics and trends shaping the future of the cannabinoid market. This blog post aims to provide valuable insights into the current state of the industry, key market metrics, and emerging opportunities for businesses and consumers alike.
The Latest Cannabinoid Industry Statistics Explained
The global cannabinoids market is projected to exhibit a CAGR of 26.3% from 2021-2028.
This statistic indicates that the global cannabinoids market is expected to grow significantly over the period from 2021 to 2028, with a compound annual growth rate (CAGR) of 26.3%. The CAGR represents the average annual growth rate of the market during this time frame. A CAGR of 26.3% suggests a strong and rapid expansion in the market for cannabinoids, which are compounds found in cannabis and hemp plants. This growth projection indicates a rising demand for cannabinoids products, likely driven by factors such as increasing legalization, regulatory changes, and growing consumer interest in health and wellness products derived from cannabinoids. This statistic highlights the potential opportunities and market dynamics that may influence the development of the global cannabinoids industry in the coming years.
The American market for cannabinoids was valued nearly USD 3.1 billion in 2020.
The statistic indicates that the American market for cannabinoids, which includes products such as CBD and medical marijuana, reached a total value of approximately USD 3.1 billion in the year 2020. This suggests a significant increase in the demand and consumption of cannabinoid products within the United States, reflecting a growing trend towards the acceptance and integration of these substances into mainstream markets. The substantial market value also underscores the potential economic impact of cannabinoids as a burgeoning industry, with opportunities for growth and investment in both medical and recreational sectors.
The global cannabinoid market was valued at $2.32 billion in 2021.
The statistic indicates that the global cannabinoid market, which includes various products derived from cannabis and hemp plants such as CBD and THC, was worth $2.32 billion in 2021. This value reflects the total revenue generated by the sale of cannabinoid products worldwide during that year. The significant market value suggests a growing demand for such products, likely driven by increasing awareness of their potential health benefits and changing regulatory landscapes in various countries. The figure also signifies the economic importance of the cannabinoid industry and its potential for further expansion in the future as more consumers integrate these products into their daily routines.
90% of U.S. consumers believe cannabinoids can offer wellness and therapeutic benefits.
The statistic “90% of U.S. consumers believe cannabinoids can offer wellness and therapeutic benefits” suggests a significant level of public perception regarding the potential benefits of cannabinoids for health. This statistic indicates that a vast majority of consumers in the United States view cannabinoids, such as CBD and THC, as having the potential to provide positive effects on well-being and health conditions. The belief in the therapeutic value of cannabinoids may stem from increasing research and anecdotal evidence supporting their use in managing conditions like chronic pain, anxiety, and sleep disorders. This high percentage of consumers holding this belief highlights a growing acceptance and interest in alternative wellness approaches involving cannabinoids in the U.S. market.
The global cannabis-infused edible market alone is predicted to be worth $116.25 billion by 2032.
The statistic stating that the global cannabis-infused edible market is projected to reach a value of $116.25 billion by 2032 indicates a significant growth and potential market expansion in the cannabis industry. The increasing legalization of cannabis in various regions, coupled with the rising acceptance and consumption of edibles as a popular mode of cannabis consumption, are key factors driving the market growth. This statistic suggests a promising future for the cannabis-infused edible market as businesses and investors look to capitalize on the projected growth opportunities in this sector.
The global cannabis market is expected to reach USD 90.4 billion by 2026.
The statistic indicates that the global cannabis market is projected to grow significantly and reach a total value of USD 90.4 billion by the year 2026. This estimate suggests a rapid expansion in the industry, driven by factors such as increasing legalization of cannabis for medical and recreational use in various countries, growing acceptance of cannabis products, and advancements in cultivation, production, and distribution technologies. The forecasted market size highlights the substantial economic potential of the cannabis industry and signifies the opportunities for businesses and investors operating within this sector to capitalize on the expanding market demand.
By 2025, the medical cannabis global market is projected to reach US$ 36.2 billion.
The statistic stating that the medical cannabis global market is projected to reach US$ 36.2 billion by 2025 indicates a significant growth trajectory for the industry. This forecasted figure suggests a substantial increase in the demand and consumption of medical cannabis products worldwide over the next few years. Factors contributing to this projected market size may include shifting attitudes towards cannabis legalization for medical purposes, increased research highlighting the potential health benefits of cannabis, and expanding access to medical cannabis products in various regions. The projected market value underscores the growing recognition and acceptance of medical cannabis as a legitimate form of treatment and investment opportunity within the healthcare and pharmaceutical sectors.
In 2019, the North American cannabinoid market accounted for the highest revenue and was valued at USD 5.2 billion.
The statistic indicates that in 2019, the North American market for cannabinoids, which includes products derived from cannabis such as CBD, THC, and other cannabinoids, generated the highest revenue compared to other regions. The market value was estimated at USD 5.2 billion, highlighting the significant economic contribution of cannabinoid products in North America. This trend suggests a growing acceptance and demand for cannabinoids in various industries, including healthcare, wellness, and recreational sectors. The statistic underscores the potential market opportunities and economic impact of cannabinoids in the region.
In 2021, the hemp-derived CBD market is estimated to reach nearly $1.8 billion.
The statistic suggests that in 2021, the market size of hemp-derived CBD products is projected to grow significantly, with an estimated value close to $1.8 billion. This growth indicates a strong and increasing demand for CBD products derived from hemp, likely driven by factors such as growing consumer awareness of the potential health benefits of CBD, expanding legalization of hemp and CBD products, and a more favorable regulatory environment. The substantial market value reflects the diverse range of CBD products available, including oils, edibles, topicals, and more, as well as the growing interest in natural and alternative wellness solutions. Overall, the statistic underscores the rapid growth and lucrative opportunities within the hemp-derived CBD market in 2021.
By 2027, the cannabidiol (CBD) market size is projected to reach USD 39.99 billion.
The statistic states that the market size for cannabidiol (CBD) products is forecasted to grow significantly and reach a value of USD 39.99 billion by the year 2027. This projection suggests a substantial expansion in the demand and consumption of CBD products such as oils, edibles, topicals, and other wellness products over the next few years. The growing popularity of CBD products can be attributed to various factors, including increased awareness of potential health benefits, changing regulations, and expanding product availability. The projected market size indicates a promising growth opportunity for businesses operating in the CBD industry and reflects the evolving landscape of the cannabis market.
85% of research in the cannabinoid market is focused on Epidiolex in the treatment of rare childhood seizures.
The statistic that 85% of research in the cannabinoid market is focused on Epidiolex in the treatment of rare childhood seizures indicates a significant concentration of scientific interest and resources in exploring the therapeutic potential of this particular cannabinoid-based medication for specific medical conditions. This high percentage suggests that Epidiolex has emerged as a prominent player in cannabinoid research, particularly in the context of addressing rare childhood seizures. The targeted focus on Epidiolex implies its perceived effectiveness or unique pharmacological properties in addressing this specific health issue, potentially demonstrating promising outcomes that justify the substantial allocation of research efforts towards its further study and development.
The Cannabidiol (CBD) market in the U.S. is estimated to surpass $20 billion by 2024.
The statistic regarding the Cannabidiol (CBD) market in the U.S. surpassing $20 billion by 2024 indicates a significant growth trajectory for the industry. CBD, a non-psychoactive compound derived from cannabis, has surged in popularity due to its potential health benefits and various applications in wellness products. The estimated value reflects the increasing acceptance and consumer demand for CBD products, ranging from oils and topicals to edibles and beverages. This projection suggests a thriving market landscape with ample opportunities for businesses and investors operating within the CBD industry.
Total active hemp licenses in the U.S. increased 455% from 2018 to 2019.
The statistic that total active hemp licenses in the U.S. increased by 455% from 2018 to 2019 indicates a substantial growth in the hemp industry within that one-year period. This growth suggests a significant increase in interest and participation in hemp cultivation, processing, and other related activities across the country. The surge in active hemp licenses could be attributed to various factors such as the passing of the 2018 Farm Bill, which legalized industrial hemp production in the U.S., as well as the growing popularity of hemp-derived products like CBD. This statistic reflects a rapid expansion of the hemp industry and highlights the increasing opportunities and economic potential within the sector.
About 9% of CBD users in the U.S. consume it for skincare.
The statistic suggests that approximately 9% of individuals who use cannabidiol (CBD) in the United States do so specifically for skincare purposes. This implies that a notable percentage of CBD users view it as beneficial for addressing various skin-related concerns, such as acne, dryness, or inflammation. The popularity of CBD for skincare may stem from its anti-inflammatory and antioxidant properties, as well as anecdotal evidence suggesting its effectiveness in improving skin health. Understanding consumer preferences and motivations for using CBD can provide valuable insights for skincare product developers, marketers, and healthcare professionals in catering to this specific segment of the market.
An estimated 64 million Americans have tried CBD in the past 24 months.
The statistic indicates that approximately 64 million individuals in the United States have experimented with or used CBD (cannabidiol) products within the previous two years. This estimate suggests a significant level of interest and engagement with CBD among Americans, reflecting a growing trend in the adoption of CBD for various purposes such as health and wellness, pain management, and relaxation. The prevalence of CBD use in the population underscores the increasing acceptance and availability of CBD products in the market, potentially driven by consumer perceptions of the benefits associated with CBD consumption. This statistic provides insights into the widespread reach of CBD products within the American population over a relatively recent period of time.
33% of pet owners are using CBD products for their pets, according to the U.S. CBD market report.
The statistic that 33% of pet owners are using CBD products for their pets, as reported in the U.S. CBD market report, indicates a significant trend in pet care practices. This statistic suggests that a substantial portion of pet owners are turning to CBD products as a potential solution for managing their pets’ health and wellness. The increasing popularity of CBD products for pets may be driven by the perceived benefits of CBD in alleviating various health issues in animals, such as anxiety, pain, and inflammation. Additionally, this statistic highlights the growing acceptance and integration of alternative remedies in pet healthcare, reflecting a shift towards natural and holistic approaches to pet wellness among pet owners in the United States.
California is leading the U.S. CBD market with estimated sales worth around $730 million in 2019.
The statistic indicates that California holds a dominant position in the U.S. CBD market, with an estimated sales value of approximately $730 million in 2019. This data suggests that California contributes significantly to the overall revenue generated by CBD products in the country, showcasing a strong demand and consumption rate within the state. The substantial sales figure also highlights the potential economic impact of CBD products in California, reflecting a thriving market that is likely to continue growing as consumer interest in CBD continues to rise.
References
0. – https://www.www.researchandmarkets.com
1. – https://www.fortune.com
2. – https://www.www.cnbc.com
3. – https://www.www.statista.com
4. – https://www.www.forbes.com
5. – https://www.www.theatlantic.com
6. – https://www.www.globenewswire.com
7. – https://www.www.brightfieldgroup.com
8. – https://www.www.reportsanddata.com
9. – https://www.www.prnewswire.com
10. – https://www.www.alliedmarketresearch.com
11. – https://www.www.grandviewresearch.com
